In vitro activity of ramoplanin against Clostridium difficile, including strains with reduced susceptibility to vancomycin or with resistance to metronidazole.
about
Clostridium difficile infection: update on emerging antibiotic treatment options and antibiotic resistanceCadazolid: A new hope in the treatment of Clostridium difficile infectionClostridium difficile infection: molecular pathogenesis and novel therapeuticsClostridium difficile Infection in Children: Current State and Unanswered QuestionsThe potential for emerging therapeutic options for Clostridium difficile infectionA Review of Experimental and Off-Label Therapies for Clostridium difficile InfectionRamoplanin: a topical lipoglycodepsipeptide antibacterial agent.Treatment of Clostridium difficile infection: recent trial results.Progress in the discovery of treatments for C. difficile infection: A clinical and medicinal chemistry review.Future novel therapeutic agents for Clostridium difficile infection.Past, present, and future therapies for Clostridium difficile-associated disease.Generation of ramoplanin-resistant Staphylococcus aureus.Treatment strategies for recurrent and refractory Clostridium difficile-associated diarrhea.The incidence and drug resistance of Clostridium difficile infection in Mainland China: a systematic review and meta-analysis.Antimicrobial susceptibility of clostridium difficile clinical isolates in iran.Clinical update for the diagnosis and treatment of Clostridium difficile infection.Production of Ramoplanin and Ramoplanin Analogs by Actinomycetes.Recurrent Clostridium difficile infection: what are the treatment options?Management of Clostridium difficile Infection.A Clostridium difficile Lineage Endemic to Costa Rican Hospitals Is Multidrug Resistant by Acquisition of Chromosomal Mutations and Novel Mobile Genetic ElementsSuccessful use of nitazoxanide in the treatment of recurrent Clostridium difficile infection.Ambush of Clostridium difficile spores by ramoplanin: activity in an in vitro modelOutcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027.Replacement of Soybean Meal with Animal Origin Protein Meals Improved Ramoplanin A2 Production by Actinoplanes sp. ATCC 33076.Analysis of anti-Clostridium difficile activity of thuricin CD, vancomycin, metronidazole, ramoplanin, and actagardine, both singly and in paired combinations.Antimicrobial susceptibility pattern of Clostridium difficile and its relation to PCR ribotypes in a Swedish university hospitalProduction of ramoplanin analogues by genetic engineering of Actinoplanes sp.Leaping Forward in the Treatment of Clostridium Difficile Infection: Update in 2015.Investigation of halogenation during the biosynthesis of ramoplanin in Actinoplanes sp. ATCC33076.Treatment of Clostridium difficile infection.Clostridium difficile Infections: A Global Overview of Drug Sensitivity and Resistance Mechanisms.Novel Antimicrobials for the Treatment of Clostridium difficile Infection.
P2860
Q24632641-5882B0D2-7CE8-4DF9-8E3D-56B7BCDD8835Q26782461-87BA368C-C717-4B42-887F-E60843B7B9BFQ26864237-83A5BA36-89F9-43B2-8F62-AD31B5EC20D5Q27016320-193A8547-87C4-4FDB-AD1B-E781E22DA554Q28082059-223D236B-7355-4253-95FD-7FAEE3524462Q30240264-75F954E4-C11F-45B9-BFFD-EBD2BBB46234Q34593188-AEA5EB44-C5DA-4F39-8FDC-2FA87FF88869Q34710368-52AB1C92-B35B-4AD9-A255-A570A3E2F413Q35044119-F81CC498-B21D-4A30-AF44-9DC3A21CC66EQ35175136-5534CDFA-8D50-41EA-972E-E283C08FCE9EQ36674768-F6E4D331-7B4C-4879-A287-A0AD07C1E332Q36680162-92F519F5-1414-46EC-A00A-3531D6EA7183Q37346005-BE3D32EB-9AC4-43C1-8BBD-A607FBEF7324Q37449268-BC6EE16F-2FA2-4727-9A6D-F9E75A83A805Q37569179-B70CB4A6-700F-42CF-8878-CCD4DA0EE2E4Q37633859-C805363B-3336-476A-930D-4EF60534FBD7Q37681133-0D4331C8-8C78-47BB-B012-AAEFB8494ACBQ37875055-A653B71F-07F0-4941-AA5E-4A0A61DE51D5Q38787320-780DAF1F-16CD-4B3A-A690-B2BB0E64E226Q39382890-74FD6FE6-2202-4DE3-A09D-02E7FA0A1A51Q39554726-6A6B0F95-0757-44B4-8D2F-D4A24F7BF616Q39564798-58D99466-E82B-4D7F-B326-A1B392B6738BQ40438125-5B11FFBA-557C-4367-99B1-85EFB1674AD5Q40689166-CB4AAEAD-9137-49B8-89F2-E627FAA8F9FCQ42063601-0F9673C8-5C47-445D-A9D1-0B93123ED4F2Q42424817-B5CFF569-9155-4322-85BE-91BFCED652D7Q44114594-86C881F2-8E1A-4E4A-BF7B-1BAAB87E4AE2Q51084446-27F2CF2E-D29F-4773-B27A-2B63005E7440Q51694240-7A174EC3-9D4F-4271-A914-12981961E273Q51894323-654CBA2C-9AB0-4842-B17A-603ABA447802Q53692769-5E34E9BE-43D5-40D7-914C-3B599D84D646Q55405974-EC7075A9-E351-4190-BDAF-3DA5B99BD1C8
P2860
In vitro activity of ramoplanin against Clostridium difficile, including strains with reduced susceptibility to vancomycin or with resistance to metronidazole.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
In vitro activity of ramoplani ...... h resistance to metronidazole.
@ast
In vitro activity of ramoplani ...... h resistance to metronidazole.
@en
type
label
In vitro activity of ramoplani ...... h resistance to metronidazole.
@ast
In vitro activity of ramoplani ...... h resistance to metronidazole.
@en
prefLabel
In vitro activity of ramoplani ...... h resistance to metronidazole.
@ast
In vitro activity of ramoplani ...... h resistance to metronidazole.
@en
P2093
P2860
P1476
In vitro activity of ramoplani ...... h resistance to metronidazole.
@en
P2093
A Martín-López
V García-Arias
P2860
P304
P356
10.1128/AAC.49.3.1157-1159.2005
P407
P50
P577
2005-03-01T00:00:00Z